Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples

19Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diagnostic galactomannan (GM) enzyme immunoassay (EIA) testing is formally validated only for serum, though in practice, plasma is occasionally tested. It is assumed, but not confirmed, that results will be comparable to those for serum. GM EIA when testing plasma was evaluated, providing sensitivity (85.7%) and specificity (85.4%) comparable to those for serum. Plasma index values were higher than those for serum; if plasma GM EIA were used to define probable cases, four additional cases would have been diagnosed. © 2013, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

White, P. L., Jones, T., Whittle, K., Watkins, J., & Barnes, R. A. (2013). Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples. Clinical and Vaccine Immunology, 20(4), 636–638. https://doi.org/10.1128/CVI.00730-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free